Experts have stated that Olaparib could become a revolutionary treatment for prostate cancer – the first genetically targeted drug for fighting the disease. The precision medicine is already used by the NHS for ovarian cancer and has been called a game-changer by cancer doctors. Findings presented at a recent conference show how in trials, it
According to a recent study published in Cardiovascular Research, a journal of the European Society of Cardiology (ESC), people with gum disease (periodontitis) are more likely to have high blood pressure (hypertension). Senior author Professor Francesco D’Aiuto of UCL Eastman Dental Institute, UK, said: “We observed a linear association – the more severe periodontitis is, the
The Association of the British Pharmaceutical Industry (ABPI) and Birmingham Health Partners (BHP) have formed a partnership in order to “tackle the biggest health challenges” within Birmingham. The partnership, which will focus on West Midlands’ six million residents, will utilise real-time clinical trials and health data to accelerate research and improve cancer care, maternity services,
In a new study undertaken in the early stage of prostate cancer, Angle report that their test, Parsortix has demonstrated the potential to out-perform current standard of care with regards detection and assessment of the disease. To date, investigation of symptoms for prostate cancer are typically made via a blood test measuring prostate specific antigen
According to new research conducted by University of St Andrews announced that women are risking their lives by not taking part in bowel screening tests. The research team found that while 81% of women took part in cervical cancer screening and 73% in breast cancer screening, only 60% of women took part in bowel screening.
NHS England has made Roche’s emicizumab (also referred to as Hemlibra®) available on NHS and is set to fund the “life-changing treatment” for thousands of people with severe Haemophilia. A move which is said to dramatically cut patient’s risk of life-threatening bleeds and reduce treatment time. The new treatment is part of a package of
Gedeon Richter has announced that their biosimilar for osteoporosis, Teriparatide, is to be made available on the NHS for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. As a result, the NHS can now provide an additional option for the treatment of osteoporosis in this subset of patients.
As part of our thought leadership and industry innovation agenda we wanted to educate and create awareness of the new IR35 legislation via a Breakfast Seminar to allow for careful planning before April 2020! To support with the understanding of IR35, its implications and how it could affect you as a Limited Company Contractor, the
Report from Asthma UK has found that deaths from asthma attacks are the highest they have been in the last decade and increased by more than 33% over the last ten years. By analysing data from the Office for National Statistics (ONS), they revealed that more than 1,400 people died from an asthma attack last
The NHS in England is setting up a national artificial intelligence (AI) laboratory to enhance care of patients and research. Health Secretary, Matt Hancock, said AI had “enormous power” to improve care, save lives and ensure doctors had more time to spend with patients. He has announced that £250m will be spent on boosting the